Collegium Pharmaceutical, Inc.

NasdaqGS:COLL 株式レポート

時価総額:US$1.1b

Collegium Pharmaceutical バランスシートの健全性

財務の健全性 基準チェック /46

Collegium Pharmaceuticalの総株主資本は$216.6M 、総負債は$552.8Mで、負債比率は255.3%となります。総資産と総負債はそれぞれ$1.1Bと$836.8Mです。 Collegium Pharmaceuticalの EBIT は$203.8Mで、利息カバレッジ比率3.7です。現金および短期投資は$271.6Mです。

主要情報

255.3%

負債資本比率

US$552.83m

負債

インタレスト・カバレッジ・レシオ3.7x
現金US$271.63m
エクイティUS$216.58m
負債合計US$836.81m
総資産US$1.05b

財務の健全性に関する最新情報

Recent updates

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Oct 28
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Collegium Pharmaceutical: Diversifying And Growing

Aug 09

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Jul 24
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Jun 05
Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss'

May 13

It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

May 10
It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

Collegium Pharmaceutical Q4: The Beat Goes On

Feb 26

These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

Feb 24
These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Jan 05
There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Nov 12
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Aug 09
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Mar 10
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Oct 18
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Jun 24
Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Collegium Pharmaceutical: Oversold And Cheap

Jun 12

財務状況分析

短期負債: COLLの 短期資産 ( $510.2M ) が 短期負債 ( $461.7M ) を超えています。

長期負債: COLLの短期資産 ( $510.2M ) が 長期負債 ( $375.1M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: COLLの 純負債対資本比率 ( 129.8% ) は 高い と見なされます。

負債の削減: COLLの負債対資本比率は、過去 5 年間で13.4%から255.3%に増加しました。

債務返済能力: COLLの負債は 営業キャッシュフロー によって 十分にカバー されています ( 50.1% )。

インタレストカバレッジ: COLLの負債に対する 利息支払いEBIT ( 3.7 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘